颖泰生物
(833819)
| 流通市值：44.82亿 | | | 总市值：45.48亿 |
| 流通股本：12.08亿 | | | 总股本：12.26亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,137,037,084.93 | 1,477,858,022.1 | 1,548,174,207.26 | 1,506,435,119.48 |
| 应收票据及应收账款 | 1,494,132,966.17 | 1,322,423,951.84 | 1,224,109,311.13 | 973,466,781.94 |
| 应收账款 | 1,494,132,966.17 | 1,322,423,951.84 | 1,224,109,311.13 | 973,466,781.94 |
| 应收款项融资 | 67,881,964.9 | 77,016,480.84 | 63,656,824.34 | 53,480,584.17 |
| 预付款项 | 93,210,093.49 | 60,712,457.58 | 53,557,798.07 | 74,667,314.64 |
| 其他应收款合计 | 64,988,034.05 | 59,066,363.77 | 66,241,964.17 | 59,202,023.38 |
| 其中:应收利息 | 3,678,958.33 | 3,362,069.44 | 3,647,736.11 | 3,374,736.11 |
| 存货 | 1,669,389,969.1 | 1,784,645,559.6 | 1,867,662,749.39 | 1,960,686,648.98 |
| 合同资产 | 11,582,640.75 | 10,013,007.19 | 8,984,881.21 | 9,885,040.33 |
| 其他流动资产 | 204,156,567.95 | 190,223,959.55 | 180,380,614.81 | 176,318,201.22 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 4,742,379,321.34 | 4,981,959,802.47 | 5,012,768,350.38 | 4,842,717,364.14 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,849,180,801.71 | 1,942,293,745.36 | 2,013,954,323.4 | 2,027,040,796.65 |
| 其他权益工具投资 | - | - | - | 840,605.16 |
| 投资性房地产 | 113,108,225.69 | 113,385,584.57 | 112,381,278.46 | 115,228,635.01 |
| 固定资产 | 2,586,631,029.83 | 2,667,991,773.78 | 2,743,440,309.62 | 2,770,477,673.35 |
| 在建工程 | 1,627,163,128.69 | 1,567,774,190.25 | 1,437,450,808.25 | 1,383,517,302.47 |
| 使用权资产 | 45,248,853.44 | 45,732,370.04 | 46,219,809.08 | 47,569,830.49 |
| 无形资产 | 721,496,566.75 | 727,085,644.49 | 737,249,672.43 | 747,606,491.35 |
| 商誉 | 463,154,133.2 | 463,154,133.2 | 463,154,133.2 | 463,154,133.2 |
| 长期待摊费用 | 31,890,938.47 | 18,894,633.13 | 20,747,814.11 | 19,981,405.18 |
| 递延所得税资产 | 113,375,551.45 | 106,352,424.39 | 93,038,778.98 | 86,659,550.52 |
| 其他非流动资产 | 100,097,602.13 | 99,572,323 | 120,939,886.38 | 137,350,229.92 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 7,651,346,831.36 | 7,752,236,822.21 | 7,788,576,813.91 | 7,799,426,653.3 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 12,393,726,152.7 | 12,734,196,624.68 | 12,801,345,164.29 | 12,642,144,017.44 |
| 流动负债: | | | | |
| 短期借款 | 2,985,886,092.75 | 3,638,115,005.4 | 3,700,420,289.3 | 3,208,917,430.75 |
| 交易性金融负债 | 586,961.84 | 610,946.58 | 171,985.04 | - |
| 应付票据及应付账款 | 1,573,861,672.15 | 1,559,070,251.38 | 1,700,709,268.18 | 1,921,351,916.98 |
| 其中：应付票据 | 748,284,060.94 | 612,926,223.91 | 811,293,306.84 | 1,081,330,110.26 |
| 应付账款 | 825,577,611.21 | 946,144,027.47 | 889,415,961.34 | 840,021,806.72 |
| 预收款项 | - | - | - | 737,147.48 |
| 合同负债 | 117,486,696.01 | 47,339,083.8 | 85,956,512.46 | 113,606,838.79 |
| 应付职工薪酬 | 82,104,668.73 | 79,191,295.4 | 81,476,704.19 | 143,092,493.8 |
| 应交税费 | 35,610,497.3 | 55,732,066.17 | 63,934,604.91 | 63,726,854.16 |
| 其他应付款合计 | 240,462,465.53 | 358,234,875.51 | 216,473,816.88 | 238,551,248.22 |
| 应付股利 | - | 122,580,000 | - | - |
| 一年内到期的非流动负债 | 645,581,667.89 | 265,113,738.5 | 187,773,102.8 | 236,525,797.3 |
| 其他流动负债 | 10,605,241.36 | 4,693,269.12 | 8,516,341.84 | 6,914,026.56 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 5,692,185,963.56 | 6,008,100,531.86 | 6,045,432,625.6 | 5,933,423,754.04 |
| 非流动负债: | | | | |
| 长期借款 | 1,155,837,119.93 | 1,025,789,199.51 | 856,909,850.44 | 767,542,439.45 |
| 租赁负债 | 30,382,355.57 | 29,245,995.32 | 29,874,157.86 | 29,784,365.53 |
| 长期应付款 | 5,411,749.75 | 5,491,785.75 | 5,469,075.75 | 5,492,565.75 |
| 递延收益 | 64,899,454.82 | 65,669,552.42 | 65,451,369.86 | 67,389,586.96 |
| 递延所得税负债 | 47,589,748.23 | 49,621,562.22 | 47,894,087.5 | 49,972,169.46 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,304,120,428.3 | 1,175,818,095.22 | 1,005,598,541.41 | 920,181,127.15 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 6,996,306,391.86 | 7,183,918,627.08 | 7,051,031,167.01 | 6,853,604,881.19 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,225,800,000 | 1,225,800,000 | 1,225,800,000 | 1,225,800,000 |
| 资本公积 | 3,014,169,893.95 | 3,014,169,893.95 | 3,014,169,893.95 | 3,014,169,893.95 |
| 其他综合收益 | -132,862,393.54 | -95,207,163.08 | -71,499,089 | -64,239,780.05 |
| 专项储备 | 11,323,360.72 | 5,548,330.26 | 4,832,150.19 | 3,608,984.56 |
| 盈余公积 | 218,150,908.27 | 218,150,908.27 | 218,150,908.27 | 218,150,908.27 |
| 未分配利润 | 1,066,077,868.44 | 1,184,959,078.05 | 1,357,158,992.42 | 1,387,777,297.87 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,402,659,637.84 | 5,553,421,047.45 | 5,748,612,855.83 | 5,785,267,304.6 |
| 少数股东权益 | -5,239,877 | -3,143,049.85 | 1,701,141.45 | 3,271,831.65 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,397,419,760.84 | 5,550,277,997.6 | 5,750,313,997.28 | 5,788,539,136.25 |
| 负债和股东权益合计 | 12,393,726,152.7 | 12,734,196,624.68 | 12,801,345,164.29 | 12,642,144,017.44 |
| 公告日期 | 2024-10-25 | 2024-08-19 | 2024-04-25 | 2024-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |